A community health system in a large metropolitan area was looking for ways to improve its brand presence and leadership locally, where it competed with a university medical system. The system partnered with Escalent to develop a brand tracking study that not only measured brand health but identified drivers of brand health.
We needed to understand perceived strengths and weaknesses of our client’s brand and its competitors so we kicked off the project by hosting an internal workshop with leadership as well as interviews with community members. These interviews, along with our module of proven brand metrics, formed the basis of a quantitative tracking survey instrument. Using a continuous fielding approach, we were able to identify key events in the marketplace while tracking brand health.
Using Escalent’s proven brand health solution, we identified the key drivers of brand health as well as how our client’s competitors were positioning themselves among these drivers. In addition, our Action Grids isolated specific opportunities where our client could credibly grow its brand presence over time. By implementing marketing strategies related to these opportunities, our client has enjoyed improvements in its brand perception.
Wealth management firms cannot rely on NPS alone. Cogent Syndicated reveals a relationship between S&P 500 and NPS, and shares how firms can measure loyalty through it’s proprietary AIM metric.
In response to the 2022 market turmoil, institutional asset managers ramped up their outreach to their institutional clients, offering access to investment experts and sharing perspectives. However, our data says that's not enough to boost consideration among clients.
As fleets inch towards electrification, BEV startups are gaining traction with fleets due to rising familiarity and positive opinion
New EVForward study findings reveal an opportunity for OEMs to drive brand affinity and BEV purchase consideration with cross-industry partnerships
How will mRNA transform patient engagement? Learn about mRNA innovation and implications for Pharmaceuticals and Life Sciences brand, marketing, and sales teams.
A series on mRNA innovation in life sciences and biopharma. Check out part two on what the flurry of mRNA clinical trials means for brand, marketing and sales.
Escalent’s technology experts explore how understanding the origins of generative artificial intelligence (AI) can help tech companies effectively strategize on integrating generative AI into their business and offerings for maximum customer impact
Uncertainty shocks are here to stay. Brace for change with market intelligence, flexible staff augmentation and foresight.
The metaverse and emerging technology are shaping the next evolution in streaming services as consumers look for more immersive entertainment.